Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Tolbert

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cell Host & Microbe|April 12, 2019
An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular CytotoxicityNirmin Alsahafi, Nordine Bakouche, Mohsen Kazemi, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Journal of Virology|October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variantsShilei Ding, Derek Yang, Irfan Ullah, et al.
Cell Reports|December 31, 2021
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Journal of Virology|August 29, 2014
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infectionPriyamvada Acharya, William D Tolbert, Neelakshi Gohain, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases|November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable ViremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCCJonathan Richard, Michael W Grunst, Ling Niu, et al.
Journal of Virology|November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and PotencyDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Communications|December 1, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCCJonathan Richard, Michael W Grunst, Ling Niu, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Host & Microbe|April 12, 2019
An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular CytotoxicityNirmin Alsahafi, Nordine Bakouche, Mohsen Kazemi, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Journal of Virology|October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variantsShilei Ding, Derek Yang, Irfan Ullah, et al.
Cell Reports|December 31, 2021
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Journal of Virology|August 29, 2014
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infectionPriyamvada Acharya, William D Tolbert, Neelakshi Gohain, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
The Journal of Infectious Diseases|November 30, 2023
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable ViremiaMehdi Benlarbi, Jonathan Richard, Catherine Bourassa, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCCJonathan Richard, Michael W Grunst, Ling Niu, et al.
Journal of Virology|November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and PotencyDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Communications|December 1, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCCJonathan Richard, Michael W Grunst, Ling Niu, et al.
Pageof 8